Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No discussions with Big Pharma "for COVID".
The qualifier must mean something.
So what was CYDY discussing with 11 Big Pharma that was not COVID related?
Tuesday Will Be Positive
Bad results would have resulted in an immediate trial halt. That didn't happen.
Begin or finish DSMB by mid-October?
Remember how long it took CYDY to release info on M/M results after NP gave a timeframe (without explaining all the little steps needed to release results); and everyone on this forum hyped up the expected news.
I dont expect news until end of October. Then two more weeks to file EUA at FDA.
These penny stocks are self-fulfilling pump and dumps by each of us.
Fox Business News Interview
Reminds me of an old post I had July 9th.
Whatever did happen to Adam Feuerstein?
Did CYDY take him to court or get a restaining order against him?
Big Pharma Interest
What are the different ways that the 11 BP companies could become part of the Leronlimab story?
Hopster... Come on! Be more optimistic!
CYDY must be due for a dead cat bounce after dropping below $3/share.
The long term picture of Leronlimab is still good but this short term price movement is awful. It's so not clear what CYDY's execution will be to get there.
Seriously though: Thanks for your continued perspective - even if it has been unpopular on this forum.
Mymani, based on what?
J-Belfort: follow-up question worth asking...
Can your now confirm that the convalescent plasma was the big news that your source was referring to? Or is there still a competitor with FDA ties and EUA already in place that has shown results - but the news hasn't dropped yet?
Convalescent plasma doesn't really seem to be "owned" by a competing company with FDA ties.
Know What You Own
"Shameful Claims"
SP Support
Do you see support at $3.0 or $2.8?
Trump shot reference
I think he was referring to an injection of disinfectant his staff has been working on. Not Leronlimab.
Trump Press Conference
If you don't like needles, the White House is also developing a UV light bulb suppository as a COVID therapeutic.
CYDY can't even begin to compete with this!
/Sarcasim
It's hard to watch shorts endlessly lie.
Even after FDA approval, I just don't see shorts giving up their obsession with CYDY. They'll just keep attacking from future news cycles to manipulate the next group of traders.
For example: It sounds like AF is already working on his next hit piece to release after the CYDY eficancy news and before the anticipated FDA EUA to create a SP swing to trade.
I'll never understand the FCC's strict set of rules for publicly listed company initiated actions/news; while FCC also has infinite tolerance for the games short sellers play. And every long trade is immediately tallied on the market but shorting is only reported every couple of weeks. And don't get me started about naked short counterfeit shares that go completely unreported!
It's incredibly one sided.
Bobbythebus is too funny
I showed the MID TERM ($330/share) & LONG TERM ($550/share with PE=50) outlook on CYDY stock due to potential COVID revenue. That upside potential is not going to scare anyone away for a $5 a share stock.
I think Leronlimab is going to be locked up in patents for many many years.
Look at the revenue potential for the future Leronlimab treatment list
Maybe this was scary? I pointed out that something was going on between BP and NP. Then weeks later we learned from them NP DrBeen interview they had a business disagreement.
Newbie LONG investors should be scared seeing such big $$$. It can be life changing.
Serious Justdafacts question.
I think I understand your contrarian role on this forum to balance the posters who cannot even begin to entertain negative CYDY points of view. But maybe this is a dumb question for me to ask.
What type of publication or news would it take for you to have a positive outlook on CYDY specifically as a COVID treatment?
If you are waiting until an FDA approval to mitigate the majority of investment risk in CYDY, then your SP entry point is going to be very expensive.
Thanks LeronDreams
There is so much depth to TA trading based on past observations of what stocks tend to do during specific setups/patterns.
I'm trying to learn more about the appeal of different trading strategies. None of them seem to be any better than other ones. I've concluded it's all about consistancy and proficiency of whatever method one chooses.
Three Line Strike
Hopster has inspired me to read up on TA. I thought I was nuts seeing this pattern yesterday. What I dont understand: If Cydy news wasn't released today, would today's SP increase happen?
I also thought there would be more upward price action.
Outstanding shares issue bugs me
CC was well scripted
Very well organized call. The operator went out of her way to make HGEN come across as very regal. It was a lot of info rehashing and they were careful of not setting future dates or building investor expectations. Definitely trying to impress some market makers.
HGEN had to be courting Wells Fargo, Cantor and Roth Capital. I feel those questions were already in the cue before the presentation was even finished.
If you want to be selected to ask a question next time, say your VP of Emerging BioTech from Merill Lynch... instead of Private Investor.
Source of Naked Short Sellers Market Access??
Anti-vaxers support CYDY!
Someone with COVID who chooses not to get vaccinated, and gets sick from a preventable illness is going to take a hospital bed from a person with a true medical emergency. An anti-vaxer is going to look for some vaccinated medical professionals for a couple of Leronlimab shots. Hey, great for the CYDY bottom line but bad for the young father who was just in a car accident.
If someone chooses not to get vaccinated and they get sick from something easily preventable, they should be forced to pay for their own medical treatment out of pocket. It should be a non-qualified medical expense for the insured. No Medicare bailout. No COVID mortgage forgiveness. No disability pay. No government handouts. But yeah, everyone is free to make their own decision but should be forced to live with the consequences. Just don't force others to incur any of the cost of your beliefs.
Thankfully CYDY has a COVID treatment that costs less than $5000 that the FDA will approve before September.
CYDY will not participate in Operation Warp Speed
I think NP would avoid a large government clinical trial based on his past experience canceling the grant with NIH for HIV, shortly after purchasing Leronlimab.
Why put the effort into starting a new national clinical trial if both of the CYDY clinical trials will be completed & submitted to the FDA by early September (at the latest).
NP doesn't put much value into the idea of a political play to get Leronlimab approval quicker.
NP certainly wouldn't be the head honcho in an Operation Warp Speed trial.
CYDY would have to follow a bunch of bureaucratic processes to use grant money. Free government money is never 'free'.
It's certainly not the frugal thing to do with limited resources.
Party at IncellDX!
When a new shipment of clinical trial blood draws are received, BP probably shuts all the lights off and fires up a giant black light in his lab to see which samples glow Leronlimab vs unreactive placebo. No wonder he's so confident about Leronlimab and NP is all smiles. Do you think BP has a few Greatful Dead tour posters hanging in his lab?
If the sample glows and the RANTS are low then the the clinical trial is going well. If the sample doesn't glow and the RANTS are high, then it is a Day 0 sample OR its from the placebo group - both without Leronlimab. More anecdotal evidence.
I suppose it is no different than measuring low RANTS in a sample. The blood samples from participants must be simply labeled with an ID number and no other identifying information to make it harder for BP/NP to unmask the trial data early.
Thanks Cowtown Jay.
I'm not a regular enough poster on any particular ihub forum to be held in the same regard as Millstone or Engineering_Simple or MWM or you. I'm more of a guest contributor - LOL.
I've been keeping up with this forum but usually only post when I have some novel thought bouncing around in my head. The type that keeps me up at night doing mental math. Ihub is sort of like my therapeutic outlet so I don't perseverate too much.
You're doing a great job keeping a level head about this stock and navigating the middle ground on a lot of topics here. I'm sure its a welcome break from your day-to-day reality right now. My thoughts go out to you.
It was really good news
But it is only a fleeting SP reaction and the stock will idle back at $4.50/share once again.
The SP wont increase & hold until something concrete and long lasting happens: Uplisting, releasing trial results, or announcing buyout offer(s).
Gives us time to pour a few more paychecks into the stock.
I'm optimistic about tomorrow's CC...
But, there will be plenty more SP swings over the next 4 weeks for/by shorties.
The swings will just be more volatile if the support/resistance bands are stretched out because of good but incomplete clinical trial efficacy news as it trickles out.
HGEN Strong Silent Type
I have grown to understand and appreciate over the lasts few weeks talking with you all how HGEN is being 'the strong silent type'
Thank you all for that insight.
Safe as water
There's this CYDY story that is sometimes shared on the video chats about a animal safety test that was done years ago.
Lab technicians purposely overdosed a lab rat with so much Leronlimab that the rat swelled up to twice its normal size because of all the Leronlimab injected into it.
And the lab rat didn't die.
Its apparent Durrant would never make that misstep.
It was Nader's decision to commit to releasing trial information so quickly. All he had to do was be honest about the timeline and say it will take some time, but results will be released when ready. The results he released are a disappointment, not something positive after all the building expectations.
I'd hope HGEN issues a press release with a clinical trial update. Maybe that the interim data looked good or even an update on the total trial enrollment patient count.
That a crazy story.
Who's wants to share that story on the CYDY forumn?
I think the former board members are in the wrong here and obviously there is a lot of bad blood there.
But I think it is more wrong that Scott Kelly confronted these guys.
CYDY is led by inexperienced leaders. For better or worse, CYDY is the main competition for HGEN. Its still very important to have a truthful understand of the competition - you shouldn't just put blinders on and ignore them.
HGEN is very well run
* They have done a great job controlling share dilution.
* They have prevented stock price manipulation by locking up a lot of shares.
* They did a pretty good job adding new shares into the market without a huge sharp price drop (today's drop was not that terrible - knock on wood).
* They do not release news tidbits that fuel widespread speculation.
It seems HGEN will complete the full Phase 3 study and then HGEN will publicly report the results after the data has been fully analyzed.
By contrast, CYDY poorly handled the completion of their Phase 2 M/M trial. The efficacy results will still take 4+ weeks to analyze and now its stock price will be in perpetual limbo (short seller paradise) until the end of August.
I did see Millstone's post yesterday.
For whatever reason, it seems that clinical trial recruitment is always fewer patients/day then what an outsider would think. I'd try to enroll everyone that walks through the door into the trial, but it seems hospitals tend to be much more cautious. You'd think these trial enrollment periods would be much shorter. I understand why some big pharma picks hospital trial sites in Mexico, Brazil, or India where they could finish enrollment quicker.
The HGEN clinical trial location in New Hampshire is a 'token site'. I don't think HGEN will get much action up there.
iHub Schedule Slip
Looks like our mutually agreed schedule has slipped for HGEN
I still think NASDAQ listing is going to happen soon - between 7/24 and 8/7. I don't think it will affect the stock price much. HGEN is already is owned by institutional investors and insiders.
The Phase 3 does not appear to have stopped early from the interim analysis, otherwise the trial enrollment status would have changed by now. That would put the trial enrollment completion to the end of August, 4 weeks to analyze/submit results to FDA, and 2 weeks (minimum) for a emergency use authorization.
Clinical Trial Site Update based on Internet searching:
Active:
-------
Phoenix, Arizona (Mayo Clinic)
Jacksonville, Florida (Mayo Clinic)
Rochester, Minnesota (Mayo Clinic)
Lebanon, New Hampshire (Dartmouth-Hitchcok)
Charlotte, North Carolina (Atrium Health)
Semi-Active:
------------
14 competing therapeutic COVID Clinical Trials ongoing
Atlanta, Georgia (Emory University)
Does Not Appear Active:
-----------------------
No mention of Lenzilumab regarding either of these hospital site.
Dallas, Texas (Texas Health)
Orlando Florida (AdventHealth)
Cross Check Lenzilumab Potential
I saw there are a few other clinical trials for anti GM-CSF treatments for COVID. Same method of action as Lenzilumab. None as far along as the Lenzilumab P3 clinical trial.
Gimsilumab
Namilumab
Mavrilimumab
Good to see other GM-CSF treatments have reported similar success as Lenzilumab. By that I mean that HGEN is not expected to be some type of epic failure when clinical trial results are announced.
Tomorrow's Liquidity
Compare and contrast
That's what I'm trying to do. You nailed it with the rate of increase in share price based on outstanding shares! I dont think CYDY is overpriced based on the global COVID market size. I think HGEN is undervalued because of lack of public awareness about the company drug pipeline.
HGEN share price isn't moving because there is absolutely no news coming from the company. No releases, youtube videos, NASDAQ/FDA news, nothing. There's nothing to get excited (or scared) about to drive the stock price.
The price stuck at $5/share today was a mid-size buy limit order by someone trying to buy into HGEN. I just don't think there's much liquidity to quickly buy/sell 250k or 500k shares right now [for a large personal investor].
I did like MWM's observation that the 5 times in the past, volume exceeded 1M and something happen to the stock price soon after.